Related Experiment Videos
MHC-restricted autoantigen-reactive T cell clones in multiple sclerosis
C Rohowsky-Kochan1, R Troiano, S D Cook
1University of Medicine and Dentistry of New Jersey, New Jersey Medical School, Newark 07103.
Summary
Researchers isolated myelin basic protein (MBP)-reactive T cell clones from a multiple sclerosis patient. These T cells, implicated in the autoimmune disease, recognized MBP restricted by major histocompatibility complex Class II antigens.
Area of Science:
- Neuroimmunology
- Autoimmune Diseases
- Central Nervous System Disorders
Background:
- Multiple sclerosis (MS) is a central nervous system demyelinating disease with complex etiology.
- Myelin basic protein (MBP) is a key autoantigen candidate in MS, inducing experimental autoimmune encephalomyelitis (EAE).
- MBP-specific T cells, particularly T helper/inducer types restricted by MHC Class II, are crucial in MS pathogenesis.
Purpose of the Study:
- To isolate and characterize MBP-reactive T cell clones from a patient with chronic progressive multiple sclerosis.
- To investigate the functional responses and MHC restriction of these patient-derived T cells.
Main Methods:
- Isolation of T cell clones from peripheral blood of an MS patient.
- Rechallenging T cell clones with MBP and autologous lymphocytes.
- Assessing T cell responses via blastogenesis.
- Determining T cell phenotype (CD4/CD8) and MHC restriction.
Main Results:
- Successfully isolated MBP-reactive T cell clones from the MS patient's peripheral blood.
- The isolated clones exhibited blastogenic memory responses upon rechallenge with MBP.
- MBP recognition was restricted by major histocompatibility complex Class II molecules.
- Both CD4+8- and CD4-8+ MBP-reactive T cell clones were identified.
Conclusions:
- MBP-reactive T cells are present in the peripheral circulation of MS patients.
- These T cells demonstrate functional memory responses and specific MHC Class II restriction.
- The findings support the role of MBP-specific T cells in the autoimmune process of multiple sclerosis.